Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Tax Provisions (2016 - 2026)

Cumberland Pharmaceuticals' Tax Provisions history spans 16 years, with the latest figure at $23245.0 for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 142.79% to $23245.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $40256.0, a 301.28% increase, with the full-year FY2025 number at $40256.0, up 301.28% from a year prior.
  • Tax Provisions hit $23245.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $5670.0 in the prior quarter.
  • Over the last five years, Tax Provisions for CPIX hit a ceiling of $48150.0 in Q4 2022 and a floor of -$54327.0 in Q4 2024.
  • Historically, Tax Provisions has averaged $8488.3 across 5 years, with a median of $7198.0 in 2021.
  • Biggest five-year swings in Tax Provisions: surged 284.71% in 2022 and later plummeted 317.69% in 2024.
  • Tracing CPIX's Tax Provisions over 5 years: stood at $12516.0 in 2021, then surged by 284.71% to $48150.0 in 2022, then tumbled by 48.17% to $24956.0 in 2023, then plummeted by 317.69% to -$54327.0 in 2024, then soared by 142.79% to $23245.0 in 2025.
  • Business Quant data shows Tax Provisions for CPIX at $23245.0 in Q4 2025, $5670.0 in Q3 2025, and $5671.0 in Q2 2025.